Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis

Biomarker-based cancer analysis has great potential to lead to a better understanding of disease at the molecular level and to improve early diagnosis and monitoring. Unlike conventional tissue biopsy, liquid biopsy allows the detection of a large variety of circulating biomarkers, such as microRNA...

Full description

Bibliographic Details
Main Authors: Noemi Bellassai, Roberta D'Agata, Vanessa Jungbluth, Giuseppe Spoto
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fchem.2019.00570/full
id doaj-3a3bcf069392463baca692e942aac6ae
record_format Article
spelling doaj-3a3bcf069392463baca692e942aac6ae2020-11-24T21:59:55ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462019-08-01710.3389/fchem.2019.00570473690Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer DiagnosisNoemi Bellassai0Roberta D'Agata1Vanessa Jungbluth2Giuseppe Spoto3Giuseppe Spoto4Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, ItalyDipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, ItalyDipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, ItalyDipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, ItalyIstituto Nazionale di Biostrutture e Biosistemi, Università degli Studi di Catania, Catania, ItalyBiomarker-based cancer analysis has great potential to lead to a better understanding of disease at the molecular level and to improve early diagnosis and monitoring. Unlike conventional tissue biopsy, liquid biopsy allows the detection of a large variety of circulating biomarkers, such as microRNA (miRNA), exosomes, circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and proteins, in an easily accessible and minimally invasive way. In this review, we describe and evaluate the relevance and applicability of surface plasmon resonance (SPR) and localized SPR (LSPR)-based platforms for the detection of different classes of cancer biomarkers in liquid biopsy samples. Firstly, we critically discuss unsolved problems and issues in capturing and analyzing biomarkers. Secondly, we highlight current challenges which need to be resolved in applying SPR biosensors into clinical practice. Then, we mainly focus on applications of SPR-based platforms that process a patient sample aiming to detect and quantify biomarkers as a minimally invasive liquid biopsy tool for cancer patients appearing over the last 5 years. Finally, we describe the analytical performances of selected SPR biosensor assays and their significant advantages in terms of high sensitivity and specificity as well as accuracy and workflow simplicity.https://www.frontiersin.org/article/10.3389/fchem.2019.00570/fullsurface plasmon resonanceliquid biopsycancer diagnosismicroRNAexosomescirculating tumor DNA
collection DOAJ
language English
format Article
sources DOAJ
author Noemi Bellassai
Roberta D'Agata
Vanessa Jungbluth
Giuseppe Spoto
Giuseppe Spoto
spellingShingle Noemi Bellassai
Roberta D'Agata
Vanessa Jungbluth
Giuseppe Spoto
Giuseppe Spoto
Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
Frontiers in Chemistry
surface plasmon resonance
liquid biopsy
cancer diagnosis
microRNA
exosomes
circulating tumor DNA
author_facet Noemi Bellassai
Roberta D'Agata
Vanessa Jungbluth
Giuseppe Spoto
Giuseppe Spoto
author_sort Noemi Bellassai
title Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
title_short Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
title_full Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
title_fullStr Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
title_full_unstemmed Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
title_sort surface plasmon resonance for biomarker detection: advances in non-invasive cancer diagnosis
publisher Frontiers Media S.A.
series Frontiers in Chemistry
issn 2296-2646
publishDate 2019-08-01
description Biomarker-based cancer analysis has great potential to lead to a better understanding of disease at the molecular level and to improve early diagnosis and monitoring. Unlike conventional tissue biopsy, liquid biopsy allows the detection of a large variety of circulating biomarkers, such as microRNA (miRNA), exosomes, circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and proteins, in an easily accessible and minimally invasive way. In this review, we describe and evaluate the relevance and applicability of surface plasmon resonance (SPR) and localized SPR (LSPR)-based platforms for the detection of different classes of cancer biomarkers in liquid biopsy samples. Firstly, we critically discuss unsolved problems and issues in capturing and analyzing biomarkers. Secondly, we highlight current challenges which need to be resolved in applying SPR biosensors into clinical practice. Then, we mainly focus on applications of SPR-based platforms that process a patient sample aiming to detect and quantify biomarkers as a minimally invasive liquid biopsy tool for cancer patients appearing over the last 5 years. Finally, we describe the analytical performances of selected SPR biosensor assays and their significant advantages in terms of high sensitivity and specificity as well as accuracy and workflow simplicity.
topic surface plasmon resonance
liquid biopsy
cancer diagnosis
microRNA
exosomes
circulating tumor DNA
url https://www.frontiersin.org/article/10.3389/fchem.2019.00570/full
work_keys_str_mv AT noemibellassai surfaceplasmonresonanceforbiomarkerdetectionadvancesinnoninvasivecancerdiagnosis
AT robertadagata surfaceplasmonresonanceforbiomarkerdetectionadvancesinnoninvasivecancerdiagnosis
AT vanessajungbluth surfaceplasmonresonanceforbiomarkerdetectionadvancesinnoninvasivecancerdiagnosis
AT giuseppespoto surfaceplasmonresonanceforbiomarkerdetectionadvancesinnoninvasivecancerdiagnosis
AT giuseppespoto surfaceplasmonresonanceforbiomarkerdetectionadvancesinnoninvasivecancerdiagnosis
_version_ 1725846506617962496